
|
 |
Lab Resources
This page is used for documenting key online resources used within the lab. Currently just a brief table, but expect future extensions as we develop and formalize lab protocols and techiques:
| Key Resources |
Description |
| ENSEMBL, GenBank |
Genomics resources used to characterize DNA sequences and genomic context of genes affected by polyglutamine expansion between different species. |
| GEO, ArrayExpress, HDBase |
Transcriptomics resources containing extensive experimental data on mRNA expression levels for polyglutamine expansion diseases. These include both human studies across different tissues (e.g.GSE3790 - brain, GDS1331 - peripheral blood, GSE8762 - lymphocytes, muscle), in addition to animal studies (GSE10263 - R6/2, Hdh4/Q80, CHL2 mice). |
| Proteomics Data |
Proteomics databases are in their infancy compared to transcriptomics. Proteomics data for polyglutamine diseases is generally only available from original literature such as:
Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, et al. (2007) Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression. PLoS ONE 2(7): e647. |
| Metabolomics Data |
In a similar way to proteomics data, we generally have to go to original sources to obtain metabolomics data for polyglutamine diseases such as:
Tsang, T.M., Woodman, B., Mcloughlin, G.A., Griffin, J.L., Tabrizi, S.J., Bates, G.P., and Holmes, E. (2006) Metabolic Characterization of the R6/2 Transgenic Mouse Model of Huntington's Disease by High-Resolution MAS 1H NMR Spectroscopy. J. Proteome Res., 5, 3, 483 - 492. |
| Reactome, KEGG |
Biological pathway resources used to integrate within and between different levels of high-throughput data above. |
| OMIM |
Human disease database that provides a wealth of information about polyglutamine and other amyloid diseases. |
This page last modified
14 March, 2008
by Kevin Bryson
"We build too many walls and not enough bridges" (Isaac Newton 1643-1727) |